Literature DB >> 8719239

Commentary on "Physiologically based pharmacokinetic modeling as a tool for drug development".

T M Ludden1, W R Gillespie, W J Bachman.   

Abstract

Mesh：

Year:  1995        PMID： 8719239     DOI： 10.1007/BF02354274

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  4 in total

1.  Mean time parameters for generalized physiological flow models (semihomogeneous linear systems).

Authors:  D Verotta; L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

2.  From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat.

Authors:  W F Ebling; D R Wada; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

Review 3.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

4.  A semiparametric approach to physiological flow models.

Authors:  D Verotta; L B Sheiner; W F Ebling; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1989-08
  4 in total
  2 in total

Review 1.  Pharmacokinetic-pharmacodynamic guided trial design in oncology.

Authors:  Ch van Kesteren; R A A Mathôt; J H Beijnen; J H M Schellens
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

Review 2.  The role of population pharmacokinetics in drug development in light of the Food and Drug Administration's 'Guidance for Industry: population pharmacokinetics'.

Authors:  P J Williams; E I Ette
Journal:  Clin Pharmacokinet       Date:  2000-12       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.